QUOTE AND NEWS
newratings.com  Oct 27  Comment 
NEW YORK, October 23 (newratings.com) - Analysts at Barrington Research upgrade Align Technologies (ticker: ALGN) from "market perform" to "outperform." The target price is set to $22. [more]
Stock Blog Hub  Oct 26  Comment 
Align Technology Inc. (ALGN) yesterday reported financial results for the third quarter of fiscal 2009. Earnings per share were 13 cents, surpassing the Zacks Consensus Estimate of 5 cents and the year-ago earnings of 11 cents. Net Sales Net...
Market Intelligence Center  Oct 23  Comment 
Align Technology (ALGN) was upgraded today by analysts at Barrington Research and the stock is now at $17.72, up $2.34 (15.21%) on volume of 3,727,451 shares traded. The analysts upgraded ALGN to Outperform from Market Perform. Over the last 52...
StreetInsider.com  Oct 22  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Align+Technology+%28ALGN%29+Tops+Q3+EPS+by+8c+on+Strong+Revenues%3B+Guides+Above/5038471.html for the full story.
newratings.com  Oct 1  Comment 
NEW YORK, October 1 (newratings.com) - Analysts at Brean Murray reiterate their "buy" rating on Align Technology (ticker: ALGN). The target price has been raised from $15 to $18. [more]
Market Intelligence Center  Oct 1  Comment 
Align Technology (ALGN) was upgraded today by analysts at Northcoast and the stock is now at $14.35, up $0.13 (0.91%) on volume of 428,563 shares traded. The stock was upgraded to Buy from Neutral noting improvement in year-over-year domestic case...
StreetInsider.com  Sep 30  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Align+Technology+%28ALGN%29+Announces+Updates+to+Invisalign+Proficiency+Requirements/4982340.html for the full story.
Motley Fool  Sep 25  Comment 
It could change everything -- especially the value of your portfolio.
newratings.com  Sep 24  Comment 
NEW YORK, September 24 (newratings.com) - Analysts at Sun Trust Robinson Humphrey initiate coverage of Align Technology (ticker: ALGN) with a "buy" rating. The target price is set to $19. [more]
PR Newswire  Sep 15  Comment 
SANTA CLARA, Calif., Sept. 15 /PRNewswire-FirstCall/ -- Align Technology, Inc. (Nasdaq: ALGN) today introduced new and enhanced product features designed to provide improved results for everyday clinical demands, including extrusion and rotation of
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 
RELATED WIKI ARTICLES

Related Articles

 
TOP CONTRIBUTORS
ALGN AT A GLANCE
 
 
 
 
 
 
 
 

Align Technology, Inc., founded in 1997, is engaged in the design, manufacture, and marketing of Invisalign, a proprietary system for treating malocclusion, or crooked teeth. The Invisalign product has two components, ClinCheck and Aligners. ClinCheck is an Internet-based application that allows dental professionals to simulate treatment in three dimensions, by modeling two-week stages of tooth movement. Aligners are thin, clear-plastic, removable dental appliances that are manufactured in a series to correspond to each two-week stage of the ClinCheck simulation. Aligners are customized to perform the treatment prescribed for an individual patient by dental professionals using ClinCheck. Invisalign is approved to treat patients, with any type of malocclusion, with mature upper and lower tooth structures. The company voluntarily restricts the use of Invisalign to adults and adolescents with immature structures. Typically, permanent structures occur in the later-teen years. Align does not treat children whose teeth and jaws are still developing, as the effectiveness of Invisalign relies on the company's ability to accurately predict the movement of teeth over the course of treatment. Based on its clinical studies to date, Align recommends that dental professionals use Invisalign as a complete treatment for a range of malocclusions, and as a component of treatment for severe malocclusions.


Internationally, the company operates in the regions of Europe, Asia/Pacific, and Latin America. At the end of 2007, sales in the domestic orthodontist channel represented 30% of total revenues, while sales in the domestic general practitioner (GP) channel represented 46%, and the international channel represented 20%. The remaining 5% came from education training and other revenues.




References

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki